Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
皮下注射曲妥珠单抗联合帕妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌：MetaPHER（一项IIIb期单臂安全性研究）的最终分析
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06145-3
Kuemmel, Sherko; Tondini, Carlo A; Abraham, Jacinta; Nowecki, Zbigniew; Itrych, Bartosz; Hitre, Erika; Karaszewska, Bogusława; Juárez-Ramiro, Alejandro; Morales-Vásquez, Flavia; Pérez-García, Jose Manuel; Cardona-Huerta, Servando; Monturus, Estefania; Sequi, Marco; Restuccia, Eleonora; Benyunes, Mark; Martín, Miguel
